The company’s Kinesia technology provides a telemedicine platform for assessing movement disorders such as Parkinson’s disease. Today, this technology is being developed beyond patient care, to include cutting-edge therapies such as deep brain stimulation and today clinical trials are testing new pharmaceutical interventions to treat and slow disease progression.
Since the beginning of 2012, the company has increased the number of employees from 14 to 21 full time employees. The jobs have included software engineering, biomedical engineering, firmware engineering, quality management, accounting, and human resources.
This growth has created a highly skilled workforce in the region attracting new talent to the area. In 2012, the company added over $580k in new payroll to the Northeast Ohio biotech market with additional openings at the company still being filled.
According to Lisa Halasy, Human Resources Coordinator, “We anticipate our growth and required resources to continue through 2013. As new and emerging markets for the Kinesia technology continue to expand commercial opportunities, the company anticipates continued employee growth.”
“We are proud to be a part of economic growth in the Cleveland area that can be driven by biomedical engineering and medical device development,” said President Joseph Giuffrida, PhD. “Not only are we positively affecting the lives of people living with movement disorders, we are growing an exciting company and creating opportunities for talented individuals looking to make a difference.”
For more information, go to www.glneurotech.com and for information on the company’s Kinesia technology, go to www.glneurotech.com/Kinesia.
